Fangda represented Kyowa Kirin on the deal. Kyowa Kirin, a global leading R&D company for innovative drugs, has reached a series of asset restructuring arrangements with...
Kyowa Kirin’s Asset Restructuring Arrangements with Winhealth
Swire Group’s Acquisition of a Controlling Shares of DeltaHealth China
Fangda advised Swire Group on the deal. Swire Group finalized the acquisition of the controlling shares of DeltaHealth China Limited from Eight Roads. DeltaHealth specializes in cardiovascular...